KOMZIFTI® (ziftomenib), FDA-Approved for Treatment of Adults with Relapsed or Refractory NPM1-Mutated Acute Myeloid Leukemia, Available at Biologics by McKesson
Cary, N.C. , Nov. 13, 2025 – Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease […]